DOXEPIN HYDROCHLORIDE

Product NDC
70518-3005
11-digit product format
705183005
Labeler code
70518
Product ID
70518-3005_d3d17b0d-c919-392f-e053-2995a90a449d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
DOXEPIN HYDROCHLORIDE
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA213063
Marketing category
ANDA
Marketing start
2021-02-02
Marketing end
0000-00-00
Substance
DOXEPIN HYDROCHLORIDE
Active strength
25 mg/1
Pharmacologic classes
Tricyclic Antidepressant [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3005-02023-03-14C16284748780-1f386c649-f2c6-0266-e053-dadaa90a7c1ac255a67a-8c22-4243-a799-73155898cd2b
70518-3005-02023-01-30C16284748780-1f386c649-f2c6-0266-e053-dadaa90a7c1ac255a67a-8c22-4243-a799-73155898cd2b

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3005-07051830050030 CAPSULE in 1 BLISTER PACK (70518-3005-0) 30 capsule2021-02-020000-00-00NoNoCurrent